ImmunOs Therapeutics Announces Poster Presentation at the Society for Immunotherapy of Cancer 36th Annual Meeting (SITC)
13 oct. 2021 04h15 HE
|
AKAMPION
- Preclinical data highlighting mode-of-action of lead program iosH2 Schlieren (Zurich Area), Switzerland. – October 13, 2021 – ImmunOs Therapeutics AG, a Swiss biotechnology company developing...
ImmunOs Therapeutics Appoints Jeffrey Abbey as Chief Operating Officer, Establishes Clinical Advisory Board
01 sept. 2021 04h00 HE
|
AKAMPION
- Company prepares for further growth and entry into clinical development- Prof. Andrew Scott, Dmitriy Zamarin, MD, PhD, Prof. Dr. med. Dirk Jäger, and Jeffrey M. Bockman, PhD, appointed as clinical...
Neonatal Diagnostics Company InfanDx AG Appoints Dr. Gunter Weiss as COO
04 août 2021 04h00 HE
|
AKAMPION
Dr. Weiss brings more than 15 years of experience in biomarker and in vitro diagnostics development Company launched targeted recruiting campaign for next phase of corporate life cycle Cologne,...
Neonatal-Diagnostik-Unternehmen InfanDx AG ernennt Dr. Gunter Weiss zum Chief Operating Officer
04 août 2021 04h00 HE
|
AKAMPION
Dr. Weiss verfügt über mehr als 15 Jahre Erfahrung mit der Entwicklung von Biomarkern und In-vitro-Diagnostika Unternehmen hat gezielte Rekrutierungskampagne für die nächste Phase der...
Dopavision Closes €12 Million Series A Round to Advance Digital Childhood Myopia Therapeutic Through Clinical Trials
14 juil. 2021 04h00 HE
|
AKAMPION
- Seventure Partners and Novartis Pharmaceuticals join as new investors- Transformative treatment for millions of children with myopia Berlin, Germany, July 14, 2021 --- Dopavision, a company...
Neonatal-Diagnostik-Unternehmen InfanDx schließt Serie A Finanzierung ab
13 juil. 2021 04h00 HE
|
AKAMPION
Unternehmen wirbt EUR 4 Mio. zum Erreichen wichtiger wertsteigernder Meilensteine innerhalb der nächsten 12-18 Monate einKlaus Albrecht, Alluti GmbH, wird Mitglied des Aufsichtsrats Köln,...
Neonatal Diagnostics Company InfanDx AG Completes Series A Funding
13 juil. 2021 04h00 HE
|
AKAMPION
Company raises EUR 4 million to reach key value-creating milestones over the next 12-18 monthsKlaus Albrecht, Alluti GmbH, appointed as new member of the Supervisory Board Cologne, Germany, July...
Eisbach Bio Receives EUR 8 Million Government Grant to Progress COVID-19 Antiviral Through Phase I/II Clinical Development
07 juil. 2021 04h00 HE
|
AKAMPION
MUNICH, Germany, July 7, 2021 – Eisbach Bio, a biotechnology company targeting the molecular machines that drive human disease, today announced additional financial support from the German Ministry...
Adept Neuro Reaches Key Milestone in the Development of Novel Intracerebral Stereoelectroencephalography (SEEG) Electrodes
06 juil. 2021 04h00 HE
|
AKAMPION
Second investment tranche provided by DIXI medicalPreparation of regulatory certifications and market launch Adept Neuro SA (Lausanne, Switzerland), a joint venture of DIXI Medical (Le Locle,...
Aleva Neurotherapeutics Recruits First Patient into its PMCF Study with its directSTIM™ Directional Deep Brain Stimulation System
17 juin 2021 03h00 HE
|
AKAMPION
- First system implanted at University Hospital of Dresden / Prof. Sobottka - Post-market clinical follow-up and revenue-generating study in the EU - Targeting US FDA IDE approval in Q4, 2021 ...